大分割放疗对不可治愈炎性乳腺癌的症状姑息效果
59.1%患者症状缓解≥70%,81.8%出现肿瘤反应,中位随访13个月无≥3级急慢性毒性。症状类型可预测症状缓解程度,放疗野和C反应蛋白升高可预测放射性皮肤毒性。
要点
- 大分割姑息放疗可安全有效缓解不可治愈炎性乳腺癌患者症状。
- 59.1%患者症状缓解≥70%,81.8%出现肿瘤反应,无≥3级毒性。
- 症状类型预测缓解程度,放疗野和CRP升高预测皮肤毒性。
核心结论
- 大分割姑息放疗可安全有效地缓解不可治愈症状性炎性乳腺癌患者的症状。
主要发现
- 放疗前主要症状为疼痛、出血和溢液。
- 与放疗前相比,症状缓解<30%、30-70%和≥70%的患者分别有2例(9.1%)、7例(31.8%)和13例(59.1%)。
- 中位随访13个月期间,无患者出现3级或以上急慢性毒性。
- 单因素分析中,症状类型是预测症状缓解程度的显著因素,放疗野和C反应蛋白升高是预测放射性皮肤毒性发生率的显著因素。
临床怎么用
- 对不可治愈的症状性炎性乳腺癌患者,可考虑采用总剂量42.5-55 Gy、分次2.5-3 Gy的大分割姑息放疗以缓解症状。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Incurable inflammatory breast cancer (IBC) patients occasionally suffer from general symptoms such as breast pain, bleeding, ulceration, and discharge, and thus require palliative radiotherapy (RT). Hypofractionated RT has many advantages in palliative settings, but very few studies on IBC have been conducted. This study was conducted to evaluate the effects of hypofractionated RT on symptomatic IBC patients. METHODS: Twenty-two patients with IBC who underwent hypofractionated palliative RT between 2010 and 2016 were retrospectively analyzed. RT was performed at a total dose of 42.5-55 Gy with 2.5-3 Gy per fraction. The treatment effects were evaluated with respect to symptom improvement, tumor response, and treatment-related toxicity. RESULTS: The main symptoms that the patients complained of before RT were pain, bleeding, and discharge. According to the percentage of symptom relief compared with pre-RT symptoms, the number of patients with < 30, 30-70%, and ≥ 70% were 2 (9.1%), 7 (31.8%), and 13 (59.1%), respectively. Eighteen (81.8%) patients showed tumor response. No patient experienced grade 3 or higher acute or chronic toxicity during a median follow-up period of 13 months. In univariate analysis, symptom type was a significant factor for predicting the degree of symptom relief. Meanwhile, RT field and C-reactive protein increase were significant factors for predicting the incidence of radiation-induced skin toxicity. CONCLUSIONS: Hypofractionated RT could safely and effectively relieve symptoms among incurable symptomatic IBC patients.
引用
- Choi HS, Jang HS, Kang KM, et al. Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer. Radiat Oncol. 2019. PMID: 31221161. doi:10.1186/s13014-019-1320-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。